EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model

Jean Courcier, Ingrid Leguerney iD, Baya Benatsou, Sibylle Pochon, Isabelle Tardy, Laurence Albiges, Paul-Henry Cournède iD, Alexandre De La Taille, Nathalie Lassau, Alexandre Ingels iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jean Courcier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Henri Mondor Hospital, University of Paris Est Créteil (UPEC), 94000 Créteil, France. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A.R.Tu.R. (Association pour la Recherche sur les Tumeurs du Rein) Association for kidney tumor research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Standard imaging cannot reliably predict the nature of renal tumors. Among malignant renal tumors, clear cell renal cell carcinoma (ccRCC) is the most common histological subtype, in which the vascular endothelial growth factor 2 (VEGFR-2) is highly expressed in the vascular endothelium. BR55, a contrast agent for ultrasound imaging, consists of gas-core lipid microbubbles that specifically target and bind to the extracellular portion of the VEGFR-2. The specific information provided by ultrasound molecular imaging (USMI) using BR55 was compared with the vascular tumor expression of the VEGFR-2 by immunohistochemical (IHC) staining in a preclinical model of ccRCC. Patients’ ccRCCs were orthotopically grafted onto Nod-Scid-Gamma (NSG) mice to generate patient-derived xenografts (PdX). Mice were divided into four groups to receive either vehicle or axitinib an amount of 2, 7.5 or 15 mg/kg twice daily. Perfusion parameters and the BR55 ultrasound contrast signal on PdX renal tumors were analyzed at D0, D1, D3, D7 and D11, and compared with IHC staining for the VEGFR-2 and CD34. Significant Pearson correlation coefficients were observed between the area under the curve (AUC) and the CD34 (0.84, p < 10−4), and between the VEGFR-2-specific signal obtained by USMI and IHC (0.72, p < 10−4). USMI with BR55 could provide instant, quantitative information on tumor VEGFR-2 expression to characterize renal masses non-invasively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansMiceAnimalsVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor AHeterograftsUltrasonographyMolecular ImagingContrast Media

Stichwörter der Autor:innen

BR55VEGFR-2axitinibmolecular imagingpatient’s derived xenograftrenal cell carcinomasultrasound

Substanzen

Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor AContrast Media

Autor:innen und Institutionen

  • Department of Urology, Henri Mondor Hospital, University of Paris Est Créteil (UPEC), 94000 Créteil, France.
  • Biomaps, UMR1281, INSERM, Centre National de la Recherche Scientifique (CNRS), Commissariat à l'Energie Atomique (CEA), Université Paris Saclay, 94800 Villejuif, France.
  • Department of Imaging, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
  • Bracco Suisse SA, 1201 Geneva, Switzerland.
  • Department of Urological Oncology, Gustave Roussy Cancer Campus, 94805 Villejuif, France.
  • Laboratory of Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, 91190 Gif-Sur-Yvette, France.

ORCID-Profile: Ingrid Leguerney, Paul-Henry Cournède, Alexandre Ingels

Förderung

  • A.R.Tu.R. (Association pour la Recherche sur les Tumeurs du Rein) Association for kidney tumor research

Zitieren

APA

Courcier, J., Leguerney, I., Benatsou, B., Pochon, S., Tardy, I., Albiges, L., Cournède, P. H., De La Taille, A., Lassau, N., & Ingels, A. (2023). BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216211

Vancouver

Courcier J, Leguerney I, Benatsou B, Pochon S, Tardy I, Albiges L, et al. BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216211

BibTeX
@article{Courcier2023,
  author = {Courcier, Jean and Leguerney, Ingrid and Benatsou, Baya and Pochon, Sibylle and Tardy, Isabelle and Albiges, Laurence and Cournède, Paul-Henry and De La Taille, Alexandre and Lassau, Nathalie and Ingels, Alexandre},
  title = {BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216211}
}
Kostenlos starten →